findmyKOL
Clinical trialNCT05469360Active, not recruitingPhase 1Interventional

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

SponsorNovartis PharmaceuticalsEnrollment38Alzheimer DiseaseMild Cognitive Impairment
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Finland
  • Novartis Investigative Site

    Kuopio, Finland

  • Novartis Investigative Site

    Turku, Finland

France
  • Novartis Investigative Site

    Lille, France

  • Novartis Investigative Site

    Paris, France

  • Novartis Investigative Site

    Toulouse, France

Spain
  • Novartis Investigative Site

    Valencia, Valencia, Spain

  • Novartis Investigative Site

    Barcelona, Spain

  • Novartis Investigative Site

    Barcelona, Spain

Sweden
  • Novartis Investigative Site

    Malmö, Sweden

  • Novartis Investigative Site

    Stockholm, Sweden

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Feb 2023
Primary completion
30 Jul 2026
Completion
24 Sept 2027
Last update posted
1 Jun 2026
Registered enrollment
38
Registry id
NCT05469360

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-514004-14
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.